Point-of-Care Molecular Diagnostic Platform That Skips Need for Amplification Being Developed at UCLA
The nucleic acid diagnostic platform they are developing doesn't require expensive optics, and it could be available as a manufacturing prototype in about a year.
NIST Scientists Measure Cell Mechanical Activity to Determine Antibiotic Efficacy, Resistance
Their approach is based on measuring the mechanical fluctuations of bacteria, and the effect that antibiotics have on those fluctuations.
Astrego Diagnostics has been founded to commercialize the technology for the rapid detection of bacterial antibiotic resistance in UTIs.
Great Basin Receives FDA Clearance for Stool Bacterial Pathogens Panel
The firm said that a number of hospitals and labs are expected to evaluate the panel, presenting it with about a $2.0 million annual revenue opportunity.